- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Titan Biotech's board approved the audited financial results for the quarter and year ended March 31, 2026. The board suggested a dividend of Rs. 0.50 per equity share, pending shareholder approval. FY26 net profit after tax was Rs. 27.45 Cr.